Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
Rick Kapur, Research Group Leader at Sanquin, Principal Investigator at Amsterdam UMC shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood, adding:
“Happy to see this paper out where we highlight our current understanding of Fetal-neonatal alloimmune thrombocytopenia (FNAIT) regarding diagnostics, pathophysiology and management.
New developments support the importance of identifying predictive biomarkers of fetal risk to guide antenatal management and of preventing affected pregnancies ideally by screening all pregnancies followed by prophylaxis.
With James Bussel and Jory Hirshman.
Free access till August 14.”
Title: Anti–HPA-1a fetal-neonatal alloimmune thrombocytopenia: reframing diagnostics, pathophysiology, and management
Authors: James B. Bussel, Jory M. Hirshman, Rick Kapur
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management